CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism

Hypertension

Volumn 35, Issue 3, 2000, Pages 694-698

  Mulatero, Paolo ^a   Schiavone, Domenica ^a   Fallo, Francesco ^b   Rabbia, Franco ^a   Pilon, Catia ^b   Chiandussi, Livio ^a   Pascoe, Leigh ^c   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

Aldosterone; Genetics; Hyperaldosteronism; Hypertension, essential; Polymorphism

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CYTOCHROME P450 ISOENZYME;

ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERALDOSTERONISM; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

EID: 0034075758     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.694     Document Type: Article

References (29)

1. Ganguly A. Primary aldosteronism. N Engl J Med. 1998;339:1828-1834.
2. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
3. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakao K, Imura H, Ulick S, Shizuta Y. Role of steroid 11beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci USA. 1992;89:1458-1462.
4. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol. 1991;5: 1513-1522.
5. Brand E, Chatelain N, Mulatero P, Fery I, Curnow KM, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32: 198-204.
6. Taymans SE, Pack S, Pak E, Torpy DJ, Zhuang Z, Stratakis CA. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J Clin Endocrinol Metab. 1998;83:1033-1036.
7. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res. 1995;21:437-442.
8. Fardella CE, Rodriguez H, Montero J, Zhang G, Vignolo P, Rojas A, Villarroel L, Miller W. Genetic variation in p450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab. 1996;81: 4347-4351.
9. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab. 1998;83:2573-2575.
10. Veglio F, Rabbia F, Mengozzi G, Mulatero P, Zocchi C, Martini G, Morra di Cella S, Chiandussi L. Assessment of a threshold value of the aldosterone/plasma renin activity ratio in the screening of primary aldosteronism. Intern Med. 1999;7:1-8.
11. Vallotton MB. Primary aldosteronism, I: diagnosis of primary aldosteronism. Clin Endocrinol (Oxf). 1996;45:47-52.
12. Terwilliger J, Ott J. Handbook of Human Genetic Linkage. Baltimore, Md: Johns Hopkins University Press; 1994.
13. Gordon RD. Primary aldosteronism: a new understanding. Clin Exp Hypertens. 1997;19:857-870.
14. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens. 1998;11:856-860.
15. Portrat-Doyen S, Tourniaire J, Richard O, Mulatero P, Aupetit-Faisant B, Curnow KM, Pascoe L, Morel Y. Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab. 1998;83:4156-4161.
16. Pascoe L, Curnow KM. Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids. 1995;60:81-90.
17. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 1999; 33(suppl II):II-266-II-270.
18. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM. Aldosterone secretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999; 33:703-707.
19. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation. 1998;97:569-575.
20. Takeda Y, Furukawa K, Inaba S, Miyamori I, Mabuchi H. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J Clin Endocrinol Metab. 1999;84:1633-1637.
21. Gicquel C, Bertagna X, Le Bouc Y. Recent advances in the pathogenesis of adrenocortical tumors. Eur J Endocrinol. 1995;133:133-144.
22. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chousos GP, Allolio B. Clonal composition of human adrenocortical neoplasm. Cancer Res. 1994;54:4927-4932.
23. Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y. Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf). 1994;40: 465-477.
24. Gicquel C, Xavier B, Schneid H, Leblond-Francillard M, Luton JP, Girard F, Le Bouc Y. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab. 1994;78:1444-1453.
25. Lin SR, Lee YJ, Tsai JH. Mutations of the p53 gene in human functional adrenal neoplasm. J Clin Endocrinol Metab. 1994;78:483-491.
26. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Lineham HM, Chrousos GP. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 1994; 78:790-794.
27. Perrett CW, Pistorello M, Boscaro M, Fallo F, Clayton RN. Molecular genetic studies on adrenal tumors: where phenotype does not match genotype. In: New MI, ed. Frontiers in Endocrinology. Rome, Italy: Ares-Serono Symposia Publications; 1996:139-143.
28. Pilon C, Pistorello M, Moscon A, Altavilla G, Pagotto U, Boscaro M, Fallo F. Inactivation of the p16 tumor suppressor gene in adrenocortical tumors. J Clin Endocrinol Metab. 1999;84:2776-2779.
29. Reincke M. Mutations in adrenocortical tumors. Horm Metab Res. 1998; 30:447-455.